The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Sebia sales in the US from 2017 to 2023, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Smarter leaders trust GlobalData
Sebia is a medical equipment company that provides innovative diagnostic solutions in the field of in vitro diagnostics (IVD). The company develops, manufactures and distributes cutting-edge medical devices and diagnostic assays. It provides clinical protein electrophoresis equipment and reagents for the screening and monitoring of various diseases, in the areas of diabetes, oncology (multiple myeloma), hemoglobinopathy and other rare pathologies. Sebia offers automated systems for capillary electrophoresis, gel electrophoresis and electrophoresis scanning software, among other products. It operates in Europe, the Americas, the Middle East and Asia. Sebia is headquartered in Lisses, Ile-de-France, France. Key subsidiaries of Sebia include SEBIA, Sebia Italia, Interlab, Sebia Japan and Sebia Diagnostics India.
The key metrics of Sebia related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2023 are shown below:
As Sebia is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Sebia.
For a detailed understanding of the performance of Sebia, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.
